We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Boston Scientific Corp (BSX) is a leading medical devices business with stocks listed in the US. It opened the day at US$40.38 after a previous close of US$40.43. During the day the price has varied from a low of USD40.125 to a high of USD41.48. The latest price was USD40.86 (25 minute delay). Boston Scientific is listed on the NYSE. All prices are listed in US Dollars.
Our top pick for
US stocks
Our top pick for
Long-term investing
Our top pick for
Low-cost broker
| Open | US$40.38 |
|---|---|
| High | US$41.48 |
| Low | US$40.125 |
| Close | US$40.86 |
| Previous close | US$40.43 |
| Change | US$0.43 |
| Change % | 1.0636% |
| Volume | 9,850,850 |
| 52-week range | US$34.98 - US$47.5 |
|---|---|
| 50-day moving average | US$40.3504 |
| 200-day moving average | US$42.2967 |
| Target price | US$49.82 |
| PE ratio | 71.7359 |
| Dividend yield | US$0 (0%) |
| Earnings per share (TTM) | US$0.53 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Use the fields above to explore the returns from a historical investment. Please refer to the charts further up this page to see performance over 5 years, or other periods. Past performance doesn't indicate future results. Capital is at risk.
Historical closes compared with the last close of $40.86
| 1 week (2022-06-21) | 12.56% |
|---|---|
| 1 month (2022-05-27) | -0.83% |
| 3 months (2022-03-25) | -6.07% |
| 6 months (2021-12-27) | -5.24% |
| 1 year (2021-06-28) | -5.70% |
|---|---|
| 2 years (2020-06-26) | 22.78% |
| 3 years (2019-06-28) | -4.93% |
| 5 years (2017-06-28) | 45.31% |
Valuing Boston Scientific stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Boston Scientific's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Boston Scientific's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 72x. In other words, Boston Scientific shares trade at around 72x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Boston Scientific's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.1563. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Boston Scientific's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Boston Scientific's EBITDA (earnings before interest, taxes, depreciation and amortisation) is US$3.2 billion (£2.6 billion).
The EBITDA is a measure of a Boston Scientific's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | US$12.2 billion |
|---|---|
| Operating margin TTM | 17.47% |
| Gross profit TTM | US$8.2 billion |
| Return on assets TTM | 4.2% |
| Return on equity TTM | 4.99% |
| Profit margin | 6.66% |
| Book value | 11.707 |
| Market capitalisation | US$54.4 billion |
TTM: trailing 12 months
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Boston Scientific.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Total ESG risk: 29.23
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Boston Scientific's overall score of 29.23 (as at 01/01/2019) is nothing to write home about – landing it in it in the 57th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Boston Scientific is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Environmental score: 1.51/100
Social score: 12.87/100
Governance score: 7.87/100
Controversy score: 3/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Boston Scientific scored a 3 out of 5 for controversy – a middle-of-the-table result reflecting that Boston Scientific hasn't always managed to keep its nose clean.
Boston Scientific Corp was last rated for ESG on: 2019-01-01.
| Total ESG score | 29.23 |
|---|---|
| Total ESG percentile | 56.94 |
| Environmental score | 1.51 |
| Social score | 12.87 |
| Governance score | 7.87 |
| Level of controversy | 3 |
We're not expecting Boston Scientific to pay a dividend over the next 12 months.
Boston Scientific's shares were split on a 2:1 basis on 6 November 2003. So if you had owned 1 share the day before the split, the next day you would own 2 shares. This wouldn't directly have changed the overall worth of your Boston Scientific shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Boston Scientific shares which in turn could have impacted Boston Scientific's share price.
Over the last 12 months, Boston Scientific's shares have ranged in value from as little as US$34.98 up to US$47.5. A popular way to gauge a stock's volatility is its "beta".
Beta measures a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Boston Scientific's is 0.8172. This would suggest that Boston Scientific's shares are less volatile than average (for this exchange).
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, and atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
Steps to owning and managing Nexgen Energy shares.
Steps to owning and managing Keypath Education shares.
If you want to directly fund climate solutions a green bond is a great place to start. Here is how they work.
What's the best way to invest money in Australia? Find out about robo advisors, index funds, cryptocurrency and more in this guide.
Steps to owning and managing EBR Systems shares.
Steps to owning and managing 5E Advanced Materials shares.
Steps to owning and managing Leo lithium shares.
Steps to owning and managing Besra Gold shares.
Steps to owning and managing The Lottery Corporation shares.
Steps to owning and managing Endeavour Group shares.
